Literature DB >> 1201004

Specific binding sites for 5-hydroxytryptamine on rat blood platelets.

A H Drummond, J L Gordon.   

Abstract

5-Hydroxytryptamine changes the shape of rat blood platelets by combination with a cinanserin-sensitive receptor which is not associated with the active uptake of 5-hydroxytryptamine. Binding of 5-hydroxy[3H]tryptamine to platelets at 4 degrees C demonstrates the presence of three saturable sites, and the highest-affinity site is apparently this 5-hydroxytryptamine receptor.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1201004      PMCID: PMC1165712          DOI: 10.1042/bj1500129

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  12 in total

1.  A NEW, POTENT AND SPECIFIC SEROTONIN INHIBITOR, (SQ 10,643) 2'-(3-DIMETHYLAMINOPROPYLTHIO) CINNAMANILIDE HYDROCHLORIDE: ANTISEROTONIN ACTIVITY ON UTERUS AND ON GASTROINTESTINAL, VASCULAR, AND RESPIRATORY SYSTEMS OF ANIMALS.

Authors:  B RUBIN; J J PIALA; J C BURKE; B N CRAVER
Journal:  Arch Int Pharmacodyn Ther       Date:  1964-11-01

2.  PLATELET CLUMPING IN VITRO.

Authors:  J R MITCHELL; A A SHARP
Journal:  Br J Haematol       Date:  1964-01       Impact factor: 6.998

3.  A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine.

Authors:  D T Wong; J S Horng; F P Bymaster; K L Hauser; B B Molloy
Journal:  Life Sci       Date:  1974-08-01       Impact factor: 5.037

4.  Letter: Rapid, sensitive microassay for platelet 5HT.

Authors:  A H Drummond; J L Gordon
Journal:  Thromb Diath Haemorrh       Date:  1974-05-15

5.  Effects of 5-hydroxytryptamine on platelet aggregation.

Authors:  H R Baumgartner; G V Born
Journal:  Nature       Date:  1968-04-13       Impact factor: 49.962

6.  5-Hydroxytryptamine uptake and release in relation to aggregation of rabbit platelets.

Authors:  H R Baumgartner
Journal:  J Physiol       Date:  1969-04       Impact factor: 5.182

7.  The relation between the 5-hydroxytryptamine content and aggregation of rabbit platelets.

Authors:  H R Baumgartner; G V Born
Journal:  J Physiol       Date:  1969-04       Impact factor: 5.182

8.  Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues.

Authors:  G V Born; K Juengjaroen; F Michal
Journal:  Br J Pharmacol       Date:  1972-01       Impact factor: 8.739

9.  A simple fluorimetric microassay for adenine compounds in platelets and plasma and its application to studies on the platelet release reaction.

Authors:  J L Gordon; A H Drummond
Journal:  Biochem J       Date:  1974-02       Impact factor: 3.857

10.  [On the pharmacology of tofranil (N-(3-dimethylaminopropyl)-iminodibenzyl hydrochloride].

Authors:  R DOMENJOZ; W THEOBALD
Journal:  Arch Int Pharmacodyn Ther       Date:  1959-07-01
View more
  8 in total

1.  Proceedings: Inhibition of 5-hydroxy-(3H)-tryptamine binding to rat blood platelets by 5-HT antagonists and uptake inhibitors.

Authors:  A H Drummond; J L Gordon
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  Binding of 5-hydroxytryptamine to human blood platelets [proceedings].

Authors:  D J Boullin; P A Glenton; D Molyneux; J R Peters; B Roach
Journal:  Br J Pharmacol       Date:  1977-11       Impact factor: 8.739

3.  Uptake of 14C-5-hydroxytryptamine by human and rat platelets and its pharmacological inhibition. A comparative kinetic analysis.

Authors:  M Wielosz; M Salmona; G de Gaetano; S Garattini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-12       Impact factor: 3.000

4.  Uptake of 5-hydroxytryptamine by rat blood platelets and its inhibition by adenosine 5'-diphosphate.

Authors:  A H Drummond; J L Gordon
Journal:  Br J Pharmacol       Date:  1976-04       Impact factor: 8.739

5.  5-Hydroxytryptamine and dopamine transport by rat and human blood platelets.

Authors:  J L Gordon; H J Olverman
Journal:  Br J Pharmacol       Date:  1978-02       Impact factor: 8.739

6.  The binding of haloperidol to human blood platelets and interactions with 5-hydroxytryptamine and dopamine.

Authors:  D J Boullin; D Molyneux; B Roach
Journal:  Br J Pharmacol       Date:  1978-07       Impact factor: 8.739

7.  Specific 3H-imipramine binding in human platelets. Influence of age and sex.

Authors:  S Z Langer; M S Briley; R Raisman; J F Henry; P L Morselli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

Review 8.  Platelets as a model for neurones?

Authors:  M Da Prada; A M Cesura; J M Launay; J G Richards
Journal:  Experientia       Date:  1988-02-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.